NS5A: A new target for antiviral drugs in the treatment of hepatitis C virus infection

被引：6
作者：
Debes, Jose D. [1 ]
Smith, Coleman I. [1 ]
机构：
[1] Univ Minnesota, Plymouth, MN USA
来源：
HEPATOLOGY | 2012年 / 56卷 / 03期
关键词：
GENOTYPE; 1; PROTEIN; REPLICATION; INHIBITOR; BMS-790052;
D O I：
10.1002/hep.25696
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：797 / 799
页数：3
相关论文
共 50 条
[1]   A novel substitution in NS5A enhances the resistance of hepatitis C virus genotype 3 to daclatasvir [J].
Fernandes Campos, Guilherme Rodrigues ;
Ward, Joseph ;
Chen, Shucheng ;
Bittar, Cintia ;
Vilela Rodrigues, Joao Paulo ;
Candolo Martinelli, Ana de Lourdes ;
Souza, Fernanda Fernandes ;
Leira Pereira, Leonardo Regis ;
Rahal, Paula ;
Harris, Mark .
JOURNAL OF GENERAL VIROLOGY, 2021, 102 (01)
[2]   In Vitro Antiviral Profile of Ruzasvir, a Potent and Pangenotype Inhibitor of Hepatitis C Virus NS5A [J].
Asante-Appiah, Ernest ;
Liu, Rong ;
Curry, Stephanie ;
McMonagle, Patricia ;
Agrawal, Sony ;
Carr, Donna ;
Rokosz, Laura ;
Lahser, Frederick ;
Bystol, Karin ;
Chase, Robert ;
Black, Stuart ;
Ferrari, Eric ;
Ingravallo, Paul ;
Tong, Ling ;
Yu, Wensheng ;
Kozlowski, Joseph .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (11)
[3]   Fast Hepatitis C Virus RNA Elimination and NS5A Redistribution by NS5A Inhibitors Studied by a Multiplex Assay Approach [J].
Liu, Dandan ;
Ji, Juan ;
Ndongwe, Tanya P. ;
Michailidis, Eleftherios ;
Rice, Charles M. ;
Ralston, Robert ;
Sarafianos, Stefan G. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (06) :3482-3492
[4]   In Vitro Antiviral Activity and Resistance Profile Characterization of the Hepatitis C Virus NS5A Inhibitor Ledipasvir [J].
Cheng, Guofeng ;
Tian, Yang ;
Doehle, Brian ;
Peng, Betty ;
Corsa, Amoreena ;
Lee, Yu-Jen ;
Gong, Ruoyu ;
Yu, Mei ;
Han, Bin ;
Xu, Simin ;
Dvory-Sobol, Hadas ;
Perron, Michel ;
Xu, Yili ;
Mo, Hongmei ;
Pagratis, Nikos ;
Link, John O. ;
Delaney, William .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (03) :1847-1853
[5]   Regulatory Analysis of Effects of Hepatitis C Virus NS5A Polymorphisms on Efficacy of Elbasvir and Grazoprevir [J].
Komatsu, Takashi E. ;
Boyd, Sarita ;
Sherwat, Adam ;
Tracy, LaRee ;
Naeger, Lisa K. ;
O'Rear, Julian J. ;
Harrington, Patrick R. .
GASTROENTEROLOGY, 2017, 152 (03) :586-597
[6]   Potent Hepatitis C Virus NS5A Inhibitors Containing a Benzidine Core [J].
Bae, Il Hak ;
Choi, Jin Kyu ;
Chough, Chieyeon ;
Keum, Sun Ju ;
Kim, Heesun ;
Jang, Sung Key ;
Kim, B. Moon .
ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (03) :255-258
[7]   Over-expression and characterization of NS3 and NS5A of Hepatitis C virus genotype 3a [J].
Anwar, Muhammad Ikram ;
Iqbal, Mazhar ;
Yousef, Mohammad S. ;
Rahman, Moazur .
MICROBIAL CELL FACTORIES, 2013, 12
[8]   NS5A resistance - associated substitutions in chronic hepatitis C patients with direct acting antiviral treatment failure in Turkey [J].
Sayan, Murat ;
Yildirim, Figen Sarigul ;
Akhan, Sila ;
Yildirim, Arzu Altuncekic ;
Sirin, Goktug ;
Cabalak, Mehmet ;
Demir, Mehmet ;
Can, Selver ;
Ersoz, Gulden ;
Altintas, Engin ;
Ensaroglu, Fatih ;
Akbulut, Ayhan ;
Sener, Alper ;
Deveci, Aydin .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 95 :84-89
[9]   Odalasvir Nonstructural protein 5A (NS5A) inhibitor Treatment of hepatitis C virus (HCV) [J].
Kanda, T. ;
Moriyama, M. .
DRUGS OF THE FUTURE, 2017, 42 (09) :549-553
[10]   Effects of Resistance-Associated NS5A Mutations in Hepatitis C Virus on Viral Production and Susceptibility to Antiviral Reagents [J].
Nitta, Sayuri ;
Asahina, Yasuhiro ;
Matsuda, Mami ;
Yamada, Norie ;
Sugiyama, Ryuichi ;
Masaki, Takahiro ;
Suzuki, Ryosuke ;
Kato, Nobuyuki ;
Watanabe, Mamoru ;
Wakita, Takaji ;
Kato, Takanobu .
SCIENTIFIC REPORTS, 2016, 6
12345